Journal of Allergy and Clinical Immunology: Global

JACI: Global is a peer-reviewed, open access, online publication of the American Academy of Allergy, Asthma & Immunology (AAAAI), which started publishing in 2021. It joins the other members of the AAAAI family of journals - The Journal of Allergy and Clinical Immunology (JACI) and JACI: In Practice, respectively two of the most highly-cited allergy and clinical immunology journals (2023 Journal Citation Reports, published by Clarivate Analytics).

Mission
The overall mission of JACI: Global is to provide authors with a fully Open Access journal for allergy/immunology-relevant work that includes global and regional perspectives, with no barrier to access for anyone with an internet connection.

Scope
As the AAAAI's Open Access journal, JACI: Global publishes reports describing original research - basic, translational and clinical - related to all aspects of allergy, immunology, and related fields. This very broad scope mirrors the scope of its two companion journals. In addition to translational content, JACI: Global publishes basic science, Phase I/II clinical trials, population studies, as well as regionally relevant research relating to allergy and immunology.

JACI: Global provides a (high-)quality outlet for authors whose funders require them to publish in a Gold Open Access journal. One of the journal's hallmarks is its geographic diversity, with an emphasis on global and regional research and practice. This makes the journal particularly appealing to authors working in Research4Life countries, with waivers or deep discounts of accepted Article Processing Charges (APCs) automatically provided by our publisher, Elsevier. JACI: Global also provides an important service to the growing number of funders who have joined Plan S (the European cOAlition S initiative) that requires full Open Access of research funded by its members, including the Gates Foundation, the Wellcome Trust, UK Research and Innovation, and the World Health Organization (see https://www.coalition-s.org).

For all articles submitted before 31 December 2024 there is a 50% discount on the APC.

Content
All JACI: Global content is peer-reviewed. Content flows to JACI: Global from three primary sources:

In order to facilitate the transfer of papers which are of sound science but not accepted by JACI or JACI: In Practice, JACI: Global uses the same article types as JACI.

Notice
Practitioners and researchers must always rely on their own experience and knowledge in evaluating and using any information, methods, compounds or experiments described herein. Because of rapid advances in the medical sciences, in particular, independent verification of diagnoses and drug dosages should be made. To the fullest extent of the law, no responsibility is assumed by the publisher or the American Academy of Allergy, Asthma & Immunology for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions or ideas contained in the material herein.  

Although all advertising material is expected to conform to ethical (medical) standards, inclusion in this publication does not constitute a guarantee or endorsement of the quality or value of such product or of the claims made of it by its manufacturer.